• Synexus announces clinical trial partnership with Northumbria Healthcare
  • Synexus continues to build in Eastern Europe, opening a new regional center to support global clinical trials
  • Pfizer identifies Synexus’ South African clinical research sites as INSPIRE sites – first in Africa
  • Synexus strengthens its global management team
  • Synexus celebrates its 21st birthday with a forward order book of over $100 million
  • New Managing Director for Synexus Germany
  • Quality drives Synexus to be the first to initiate the revalidation of its research doctors and CQC registration of its clinics
  • Dr Ian Smith founder and global medical director of Synexus awarded an MBE in the Queen’s New Years honours list

Who we are

Synexus, headquartered in Manchester, continues to pioneer important developments in the clinical trials industry. Through a global network of 26 Dedicated Research Centres (DRCs) in nine countries Synexus provides first class clinical trials data to its clients from pharma, biotechs and CROs.

More about Synexus

What We Do

Synexus recruits patients and runs clinical trials at its own Dedicated Research Centres staffed by full time GCP investigators who work solely on clinical trials. The Synexus model has been designed to:

  • Speed up clinical trials
  • Reduce costs
  • Provide access to millions of patients worldwide

Who We Work For

You will need to download the flash player to view this content.

Synexus’ client base comprises some of the world's leading pharma, biotechs and CROs.   

More about our clients

Our Expertise

Synexus' expertise across a growing number of therapy areas is ensuring clients reach the agreed number of patients, on time and at a competitive cost. 

More about therapy areas

Synexus Limited, Registered in England and Wales, Registered number 3724238, Registered Office: Sandringham House, Ackhurst Park, Chorley , Lancashire, PR7 1NY